HER2/neu-derived Peptides Are Shared Antigens among Human Non-Small Cell Lung Cancer and Ovarian Cancer

Cancer Research

Volumn 54, Issue 13, 1994, Pages 3387-3390

  Gazdar, Adi F ^c   Lyerly, H Kim ^b   Peoples, George E ^a   Parikh, Akhil S ^a   Eberlein, Timothy J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; OVARY CANCER; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HLA-A2 ANTIGEN; HUMANS; LUNG NEOPLASMS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0028277739     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yasumura, S., Hirabayashi, H., Svhwartz, D.R., Toso, J.F., Johnson, J.T., Herberman, R.B., and Whiteside, T.L. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res., 53: 1461-1468, 1993.
2. Viret, C., Davodeau, F., Guilloux, Y., Bignon, J.D., Semana, G., Breathnach, R., and Joterau. Recognition of shared melanoma antigen by HLA-A2-restricted cytotoxic T cell clones derived from human tumor-infiltrating lymphocytes. Eur. J. Immunol., 23: 141-146, 1993.
3. Houbiers, J.G.A., Nijman, H.W., van der Burg, S.H., Drijfhout, J.W., Kenemans, P., van de Velde, C.J.H., Brand, A., Momburg, F., Kast, W.M., and Melief, C.J.M. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p. 3. Eur. J. Immunol., 23: 2072-2076, 1993.
4. Gedde-Dahl, T., III, Fossum, B., Eriksen, J.A., Thorsby, E., and Gaudernack, G. T cell clones specific for p. 1 Ras-derived peptides: characterization of their fine specificity and HLA restriction. Eur. J. Immunol., 23: 754-760, 1993.
5. Peace, D.J., Smith, J.W., Chen, W., You, S.G., Cosand, W.L., Blake, J., and Cheever, M.A. Lysis of Ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated Ras peptides. J. Exp. Med., 179: 473-479, 1994.
6. Yoshino, I., Peoples, G.E., Goedegebuure, P.S., Maziarz, R., and Eberlein, T.J. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer. J. Immunol., 152: 2393-2400, 1994.
7. Minna, J.D., Pass, H., Glatstein, E., and Ihde, D.C. Cancer of the lung. In: V.T. Devita, Jr., S. Hellman, S.A. Rosenberg (eds.), Principals and Practice of Oncology, pp. 591-705. Philadelphia: Lippincott, 1989.
8. Rosenberg, S.A., Lotze, M.T., Yang, J.C., Aebersold, P.M., Linehan, W.M., Seip, C.A., and White, D.E. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann. Surg., 210: 272-285, 1989.
9. Kradin, R.L., Kurnick, J.T., Lazarus, D.S., Preffer, F., Dubinett, S.M., Pinto, C.E., Giffoerd, B., Callahan, R.J., and Strauss, H.W. Tumor-infiltrating lymphocytes and interleukin-2 treatment of advanced cancer. Lancet, 1: 577-580, 1989.
10. Weiner, D.B., Nordberg, J., Robinson, R., Nowell, P.C., Gazdar, A., Greene, M.I., Williams, W.V., Cohen, J.A., and Kern, J.A. Expression of the neu gene-encoded protein (p. 85neu) in human non-small cell carcinoma of the lung. Cancer Res., 50: 421-425, 1990.
11. Tsai, C.M., Chang, K.T., Perung, R.P., Mitsudomi, T., Chen, M.H., Kadoyama, C., and Gazdar, A.F. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER2/neu gene expression but not with ras gene mutation. J. Natl. Cancer Inst., 85: 897-901, 1993.
12. Peoples, G.E., Schoof, D.D., Andrews, J.V.R., Goedegebuure, P.S., and Eberlein, T.J. T-Cell recognition of ovarian cancer. Surgery, 114: 227-234, 1993.
13. Gazdar, A.F., and Oie, H.K. Cell culture methods for human lung cancer. Cancer Genet. Cytogenet., 19: 5-10, 1986.
14. Wei, M.L., and Cresswell, P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (Lond.), 356: 443-446, 1993.
15. Ruppert, J., Sidney, J., Celis, E., Kubo, R.T., Grey, H.M., and Sette, A. Prominant role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell, 74: 929-937, 1993.
16. Peoples, G.E., Goedegebuure, P.S., Andrews, J.V.R., Schoof, D.D., and Eberlein, T.J. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. J. Immunol., 151: 5481-5491, 1993.
17. Disis, M.L., Smith, J.W., Murphy, A.E., Chen, W., and Cheever, M.A. In vitro generation of human cytolytic T-cells specific for peptides derived from the HER2/ neu protooncogene protein. Cancer Res., 54: 1071-1076, 1984.
18. Ioannides, C.G., Fisk, B., Fan, D., Biddison, W.E., Wharton, T., and O'Brian, C.A. Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER2/neu proto-oncogene. Cell. Immunol., 151: 225-234, 1993.
19. Kern, J.A., Schwartz, D.A., Nordberg, J.E., Weiner, D.B., Greene, M.I., Torney, L., and Robinson, R.A. p. 85neu expression in human lung adenocarcinoma predicts shortened survival. Cancer Res., 50: 5184-5187, 1990.
20. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A., and Press, M.F. Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.